Fortress Biotech (FBIO) Restructuring Costs (2016 - 2018)

Fortress Biotech's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.7 million for Q3 2018.

• In Q3 2018, Restructuring Costs fell 52.19% year-over-year to $1.7 million; the TTM figure through Sep 2018 stood at $7.3 million (down 3.91% YoY), while the FY2017 annual figure was $8.8 million, up 2696.19% from the prior year.
• Restructuring Costs for Q3 2018 stood at $1.7 million, down from $2.3 million in the prior quarter.
• The five-year high for Restructuring Costs was $3.6 million in Q3 2017, with the low at $315000.0 in Q4 2016.
• The 3-year median for Restructuring Costs is $1.8 million (2018), against an average of $1.9 million.
• The sharpest annual moves came in 2017 and 2018: Restructuring Costs surged 373.97% in 2017, then slumped 52.19% in 2018.
• Fortress Biotech's Restructuring Costs stood at $315000.0 in 2016, then soared by 373.97% to $1.5 million in 2017, then advanced by 15.61% to $1.7 million in 2018.
• Business Quant data shows FBIO's Restructuring Costs at $1.7 million in Q3 2018, $2.3 million in Q2 2018, and $1.8 million in Q1 2018.